🕵️ ESSA Pharma Inc. ($EPIX)
SEC insider & ownership activity, last 12 months · CIK 1633932 · every row links its SEC filing
Over the last 12 months insiders sold $293 with no open-market buying against it. BVF Partners L P/IL sold $293 in discretionary trades (Aug). Soleus Capital Master Fund, L.P. added 5.1% → 9.8%. One red-flag 8-K in the window: Delisting notice (3.01), Oct 9, 2025.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
0 buyers, $0 (0 lots) · 1 seller, $293 (3 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| BVF Partners L P/IL | 0 | – | 3 | $293 | Aug 5, 2025 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Soleus Capital, LLC | 9.8% | 13D | Jul 17, 2025 | filing ↗ | |
| Soleus Capital Group, LLC | 9.8% | 13D | Jul 17, 2025 | filing ↗ | |
| Soleus Capital Management, L.P. | 9.8% | 13D | Jul 17, 2025 | filing ↗ | |
| Soleus GP, LLC | 9.8% | 13D | Jul 17, 2025 | filing ↗ | |
| Guy Levy | 9.8% | 13D | Jul 17, 2025 | filing ↗ | |
| Soleus Capital Master Fund, L.P. | 9.8% | 13D | Jul 17, 2025 | filing ↗ | |
| BML Investment Partners, L.P. | 9.5% | 13D | Apr 24, 2025 | filing ↗ | |
| Soleus Capital Master Fund, L.P. | 5.1% | 13G | Feb 11, 2025 | filing ↗ | |
| Soleus Capital, LLC | 5.1% | 13G | Feb 11, 2025 | filing ↗ | |
| Soleus Capital Group, LLC | 5.1% | 13G | Feb 11, 2025 | filing ↗ | |
| Soleus Capital Management, L.P. | 5.1% | 13G | Feb 11, 2025 | filing ↗ | |
| Soleus GP LLC | 5.1% | 13G | Feb 11, 2025 | filing ↗ | |
| Guy Levy | 5.1% | 13G | Feb 11, 2025 | filing ↗ |
Planned insider sales (Form 144)
No sale notices filed in the last 12 months.
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Acquisition or disposition (2.01) | Oct 9, 2025 | filing ↗ |
| Delisting notice (3.01) | Oct 9, 2025 | filing ↗ |
| Material Modifications to Rights of Security Holders (3.03) | Oct 9, 2025 | filing ↗ |
| Change of control (5.01) | Oct 9, 2025 | filing ↗ |
| Officer/director changes (5.02) | Oct 9, 2025 | filing ↗ |
| Other events (8.01) | Oct 9, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Oct 9, 2025 | filing ↗ |
| Shareholder vote (5.07) | Oct 3, 2025 | filing ↗ |
| Other events (8.01) | Oct 3, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Oct 3, 2025 | filing ↗ |
| Other events (8.01) | Sep 30, 2025 | filing ↗ |
| Other events (8.01) | Sep 30, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Sep 30, 2025 | filing ↗ |
| Material agreement (1.01) | Sep 23, 2025 | filing ↗ |
| Other events (8.01) | Sep 23, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Sep 23, 2025 | filing ↗ |
| Other events (8.01) | Sep 10, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Sep 10, 2025 | filing ↗ |
| Other events (8.01) | Aug 25, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 25, 2025 | filing ↗ |
| Other events (8.01) | Aug 13, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 13, 2025 | filing ↗ |
| Other events (8.01) | Aug 5, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 5, 2025 | filing ↗ |
| Other events (8.01) | Jul 31, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jul 31, 2025 | filing ↗ |